Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Kenalog Spray Generic Name & Formulations
Legal Class
Rx
General Description
Triamcinolone acetonide 0.2%.
Pharmacological Class
Corticosteroid.
How Supplied
Spray—100g
Manufacturer
Generic Availability
YES
Kenalog Spray Indications
Indications
Corticosteroid-responsive dermatoses.
Kenalog Spray Dosage and Administration
Adults and Children
Apply sparingly 3–4 times daily.
Kenalog Spray Contraindications
Not Applicable
Kenalog Spray Boxed Warnings
Not Applicable
Kenalog Spray Warnings/Precautions
Warnings/Precautions
Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Use lowest effective dose and potency (esp. in children). Flammable. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
Kenalog Spray Pharmacokinetics
See Literature
Kenalog Spray Interactions
Not Applicable
Kenalog Spray Adverse Reactions
Adverse Reactions
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.
Kenalog Spray Clinical Trials
See Literature
Kenalog Spray Note
Not Applicable
Kenalog Spray Patient Counseling
See Literature
